Get started
Author

Vaibhav Nigam

ORCID: 0009-0008-9502-7404
Observed ORCID: 0009-0008-9502-7404
OpenAlex ID: A5113063660
A New Insight Into The Huisgen Reaction: Heterogeneous Copper Catalyzed Azide‐Alkyne Cycloaddition for the Synthesis of 1,4‐Disubstituted Triazole (From 2018–2023)
2024 · Shivani Kasana, Vaibhav Nigam, et al. · Chemistry & Biodiversity · 30
Recent green chemistry approaches for pyrimidine derivatives as a potential anti-cancer agent: An overview (2013–2023)
2023 · Kumari Kajal, Ruchi Shakya, et al. · Sustainable Chemistry and Pharmacy · 30
Ball-mill-assisted mechanochemical approaches for heterocyclic compound synthesis (2015–2024)
2025 · Mohd. Rashid, Shivani Kasana, et al. · Molecular Diversity · 20
Revolutionizing Indole Synthesis: A Microwave‐Powered Approach
2024 · Vaibhav Nigam, Surbhi Singh, et al. · ChemistrySelect · 15
Advances in the design, discovery, and optimization of aurora kinase inhibitors as anticancer agents
2025 · Anubhav Verma, Pradhuman Bharatiya, et al. · Expert Opinion on Drug Discovery · 3
Targeting c-Met in Cancer Therapy: Unravelling Structure-activity Relationships and Docking Insights for Enhanced Anticancer Drug Design
2024 · Surbhi Singh, Vaibhav Nigam, et al. · Current Topics in Medicinal Chemistry · 3
In Silico Exploration of Algal-Derived Anticancer Agents: Insights from Molecular Docking, Dynamics, DFT and Toxicity Profiling
2025 · Vaibhav Nigam, Md Mustahidul Islam, et al. · Journal of Computational Biophysics and Chemistry · 1
Caspases activity assay procedures
2024 · Sourabh Satapathy, Shivam Kumar, et al. · Elsevier eBooks · 1
Computational Approaches to Identifying Potent FAK Inhibitors: A Molecular Docking and Toxicity Study
2024 · Surbhi Singh, Vaibhav Nigam, et al. · International Journal of Newgen Research in Pharmacy & Healthcare
Works count: 10
Citation count: 103
H-index: 4
I10-index: 4
Year
Topic
Type